Drug Detail

Drug Name JNJ-64041757
Trade Name
Synonyms ADU-214|JNJ-757
Drug Descriptions

JNJ-64041757 is a immunotherapy based on live attenuated Listeria monocytogenes, which may enhance immune response against mesothelin-expressing tumor cells (J Thoracic Oncol, Vol 12, Issue 11, S2151).



  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
JNJ-64041757 JNJ-64041757 1 0
JNJ-64041757 + Nivolumab JNJ-64041757 Nivolumab 0 1

Additional content available in CKB BOOST